SRTA
NASDAQStrata Critical Medical Inc.
News25/Ratings3
News · 26 weeks56+500%
2026-03-012026-08-23
Mix2690d
- Insider18(69%)
- SEC Filings3(12%)
- Other2(8%)
- M&A1(4%)
- Leadership1(4%)
- Earnings1(4%)
Latest news
25 items- INSIDERDirector Love Reginald sold $29,273 worth of shares (5,091 units at $5.75), decreasing direct ownership by 3% to 146,481 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- SECSEC Form 10-Q filed by Strata Critical Medical Inc.10-Q - Strata Critical Medical, Inc. (0001779128) (Filer)
- SECStrata Critical Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- INSIDERDirector Cook William L. Iii was granted 44,438 shares, increasing direct ownership by 83% to 97,671 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERDirector Wiesenthal Robert S was granted 50,234 shares, increasing direct ownership by 0.95% to 5,325,896 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERDirector Love Reginald was granted 37,675 shares, increasing direct ownership by 33% to 151,572 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERDirector Lauck Andrew was granted 35,260 shares, increasing direct ownership by 26% to 170,902 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERDirector Philip Edward M was granted 30,913 shares, increasing direct ownership by 13% to 265,078 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and CFO Heyburn William A. was granted 360,231 shares and covered exercise/tax liability with 199,209 shares, increasing direct ownership by 10% to 1,710,019 units (SEC Form 4) to satisfy withholding obligation4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERChief Accounting Officer Cohen Amir was granted 69,206 shares and covered exercise/tax liability with 34,015 shares, increasing direct ownership by 24% to 181,799 units (SEC Form 4) (withholding obligation)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and General Counsel Tomkiel Melissa M. covered exercise/tax liability with 212,309 shares and was granted 415,882 shares, increasing direct ownership by 11% to 2,096,347 units (SEC Form 4) (for withholding tax)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCEO, Logistics Wunsch Scott M was granted 57,172 shares and covered exercise/tax liability with 13,992 shares, increasing direct ownership by 7% to 668,754 units (SEC Form 4) (withholding tax)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- PRStrata Critical Medical Schedules Second Quarter 2026 Earnings Conference CallNEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the second quarter ended July 31, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be prov
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Strata Critical Medical Inc.SCHEDULE 13G/A - Strata Critical Medical, Inc. (0001779128) (Subject)
- PRStrata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery PlatformNetwork of experienced transplant surgeons in key markets will immediately become available to all Strata customersAdds significant scale to Transplant Clinical, Strata’s fastest growing business line, with a similar, rapid growth trajectory$21.5 million acquisition completed at mid-single-digit multiple of Adjusted EBITDA, pre-synergy, consistent with Strata’s capital deployment strategy NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program ("HLT-NRP"), a provider of transplant surgical recovery services in the United
- INSIDERAmendment: Co-CEO and CFO Heyburn William A. covered exercise/tax liability with 31,671 shares, decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) to satisfy tax liability4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERAmendment: Co-CEO and General Counsel Tomkiel Melissa M. covered exercise/tax liability with 29,730 shares, decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for tax liability)4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERAmendment: Chief Accounting Officer Cohen Amir covered exercise/tax liability with 4,655 shares, decreasing direct ownership by 3% to 146,608 units (SEC Form 4) to satisfy withholding tax4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERAmendment: CEO, Logistics Wunsch Scott M covered exercise/tax liability with 5,550 shares, decreasing direct ownership by 0.88% to 625,574 units (SEC Form 4) to satisfy tax liability4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- SECSEC Form SCHEDULE 13G filed by Strata Critical Medical Inc.SCHEDULE 13G - Strata Critical Medical, Inc. (0001779128) (Subject)
- INSIDERCo-CEO and CFO Heyburn William A. sold $185,909 worth of shares (31,671 units at $5.87), decreasing direct ownership by 2% to 1,548,997 units (SEC Form 4) (for withholding tax)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and General Counsel Tomkiel Melissa M. sold $174,515 worth of shares (29,730 units at $5.87), decreasing direct ownership by 2% to 1,892,774 units (SEC Form 4) (for withholding tax)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERChief Accounting Officer Cohen Amir sold $27,325 worth of shares (4,655 units at $5.87), decreasing direct ownership by 3% to 146,608 units (SEC Form 4) (tax withholding)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCEO, Logistics Wunsch Scott M sold $32,578 worth of shares (5,550 units at $5.87), decreasing direct ownership by 0.88% to 625,574 units (SEC Form 4) to satisfy withholding tax4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- SECStrata Critical Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
SRTA FAQ
6 questionsWhere does SRTA stock trade?
Strata Critical Medical Inc. (SRTA) is listed on NASDAQ.What sector and industry is SRTA in?
Strata Critical Medical Inc. operates in the Consumer Discretionary sector, Transportation Services industry.When did Strata Critical Medical Inc. go public?
Strata Critical Medical Inc. (SRTA) completed its IPO in 2019.What are analysts saying about SRTA?
Strata Critical Medical Inc. has had 3 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $800.00 price target on 2026-03-25. Recent price targets cluster around $800.00.What companies are similar to SRTA?
Notable peers in the same industry include BKNG (Booking Holdings Inc.), EXPE (Expedia Group Inc.), XPO (XPO Inc.), GATX (GATX Corporation), MMYT (MakeMyTrip Limited). Compare SRTA side-by-side with any of them on Quantisnow.How can I track SRTA on Quantisnow?
Quantisnow aggregates Strata Critical Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SRTA to receive live email and push alerts on every new disclosure.